Serum Protein Electrophoresis (SPEP): 5 Albumin/Globulin Zones, M-Spike Identification, and Immunofixation

Serum Protein Electrophoresis (SPEP) is a foundational analytical technique that separates circulating serum proteins based on their net electrical charge, molecular mass, and shape in an alkaline buffer (pH 8.6). Under standard alkaline conditions, all serum proteins acquire a negative net electrical charge and migrate toward the positive electrode (anode).

Serum proteins resolve into five distinct canonical anatomical zones (or fractions) on agarose gel or capillary zone electrophoresis:

$Anode (+) longleftarrow Albumin longleftarrow α₁-Globulin longleftarrow α₂-Globulin longleftarrow β-Globulin longleftarrow γ-Globulin longrightarrow Cathode (-)$

1. Albumin: The fastest-migrating and largest single fraction, representing 55% to 65% of total serum protein. Synthesized exclusively by the liver; responsible for 75–80% of plasma oncotic pressure and acts as the universal carrier for unconjugated bilirubin, calcium, fatty acids, and drugs.
2. Alpha-1 ($\alpha_1$) Globulins: Comprises $\alpha_1$-antitrypsin (accounting for > 90% of this band; a critical serine protease inhibitor protecting lung elastin) and $\alpha_1$-acid glycoprotein (orosomucoid).
3. Alpha-2 ($\alpha_2$) Globulins: Comprises $\alpha_2$-macroglobulin (a massive 720 kDa protease inhibitor retained during glomerular injury) and haptoglobin (binds free hemoglobin released during intravascular hemolysis).
4. Beta ($\beta$) Globulins: Typically resolved into two distinct sub-bands on capillary electrophoresis:

• Beta-1 ($\beta_1$): Dominated by transferrin (the iron transport protein).
• Beta-2 ($\beta_2$): Comprises $\beta$-lipoprotein (LDL) and complement component C3.

1. Gamma ($\gamma$) Globulins: The slowest-migrating zone, closest to the cathode. Formed by polyclonal immunoglobulins (antibodies) secreted by mature plasma cells: IgG (80%), IgA (15%), IgM (5%), and trace IgD/IgE.

The cardinal clinical objective of SPEP is the detection, quantification, and characterization of monoclonal immunoglobulins (paraproteins or M-proteins) produced by clonal expansions of B-cells or plasma cells.

Strict pre-analytic adherence prevents false-positive paraprotein interpretations:

Reference intervals based on total serum protein (60–80 g/L or 6.0–8.0 g/dL) on capillary zone electrophoresis:

1. Suspected Plasma Cell Dyscrasia:

• Unexplained normocytic normochromic anemia.
• Unexplained pathological fractures, lytic bone lesions, or persistent back pain.
• Unexplained hypercalcemia.
• Unexplained renal failure (especially with disproportionately low or negative routine dipstick proteinuria).
• Markedly elevated erythrocyte sedimentation rate (ESR > 100 mm/h) or elevated total serum protein with normal albumin.

1. Investigation of Peripheral Neuropathy: Unexplained sensorimotor peripheral neuropathy (screening for paraproteinemic neuropathy, POEMS syndrome, or AL amyloidosis).
2. Evaluation of Hyperviscosity Syndrome: Epistaxis, retinal hemorrhages, visual blurring, confusion, dizziness (Waldenström macroglobulinemia or high-titer myeloma).
3. Suspected Primary AL Amyloidosis: Nephrotic syndrome, non-ischemic cardiomyopathy with thickened ventricular walls, hepatomegaly, macroglossia, periorbital purpura ("raccoon eyes").

Step 1: Inspect Total Protein and Albumin Concentration
   ├─ Albumin < 30 g/L with marked Alpha-2 elevation ──> Nephrotic syndrome pattern
   └─ Total Protein > 85 g/L with normal albumin ────────> Suspect paraproteinemia or polyclonal gammopathy

Step 2: Examine the Gamma and Beta Densitometric Tracing
   ├─ Narrow, tall, symmetrical spike ("church spire") ─> MONOCLONAL M-SPIKE -> Proceed to Step 3
   ├─ Broad, diffuse, rounded dome ────────────────────> POLYCLONAL HYPERGAMMAGLOBULINEMIA (Infection, Liver, Autoimmune)
   ├─ Confluent plateau spanning beta and gamma ───────> BETA-GAMMA BRIDGING (Hepatic Cirrhosis)
   └─ Flattened, suppressed gamma region (< 5 g/L) ────> HYPOGAMMAGLOBULINEMIA (Primary immune defect, CLL, Light chain myeloma)

Step 3: Characterize and Quantify the Monoclonal Peak
   ├─ Quantify M-spike size via perpendicular drop integration (e.g., 18 g/L)
   └─ Order STAT Immunofixation Electrophoresis (IFE) to identify heavy chain (IgG, IgA, IgM) and light chain (kappa, lambda)

Step 4: Check the Diagnostic Triad: SPEP + IFE + Serum Free Light Chains (sFLC)
   ├─ If SPEP is completely normal but myeloma is suspected:
   │     └─ sFLC detects Light Chain Myeloma (15-20% of cases missed by SPEP alone!)
   └─ Rule out CRAB End-Organ Criteria (Calcium, Renal, Anemia, Bone lytic lesions)

SLiM Biomarkers of Malignancy (IMWG 2014):

• S: Sixty percent (≥ 60%) clonal bone marrow plasma cells.
• Li: Light chain ratio: involved/uninvolved serum free light chain ratio ≥ 100 (with involved light chain ≥ 100 mg/L).
• M: MRI: > 1 focal bone marrow lesion (≥ 5 mm in size).

• Early Acute Phase: Marked increase in α₁ (acid glycoprotein) and α₂ (haptoglobin) globulins with mild depression in albumin. Typical of acute bacterial pneumonia, myocardial infarction, or surgery.
• Chronic Inflammation: Persistent elevated α₁ and α₂ accompanied by a broad polyclonal gamma globulin increase.

• Marked, selective urinary loss of intermediate-mass proteins through damaged glomerular basement membrane.
• Densitometry: Profoundly depressed albumin (< 25 g/L), depressed gamma globulins, with a massive, sharp elevation of Alpha-2 Macroglobulin (too large at 720 kDa to cross the glomerulus; liver synthesizes it in excess).

• Complete flattening or absence of the α₁-globulin band (< 1.0 g/L).
• Strongly suggests congenital $\alpha_1$-antitrypsin deficiency (PiZZ genotype); associated with early-onset panacinar pulmonary emphysema and childhood/adult cirrhosis.

1. Therapeutic Monoclonal Antibodies:

• Modern oncology biologics (e.g., daratumumab [anti-CD38], isatuximab, elotuzumab) are humanized IgG kappa monoclonal antibodies.
• When administered to patients with multiple myeloma, the drug circulates in therapeutic concentrations (0.5–1.0 g/L), appearing on SPEP/IFE as a small IgG kappa band that completely mimics residual or relapsed myeloma!
• Confirmed using the Daratumumab-Specific Immunofixation Reflex Assay (DIRA) or mass spectrometry.

1. Radiographic Contrast Media:

• Certain intravascular iodinated contrast agents administered within 24 hours of blood collection migrate in the β-γ region, producing a transient pseudo-paraprotein artifact.

1. Fibrinogen Contamination:

• Blood drawn from heparinized vascular access lines or partially clotted serum contains fibrinogen, creating a sharp pseudo-spike at the β-γ boundary.

• SPEP Alone Misses 15–20% of Multiple Myelomas:
• In Light Chain Multiple Myeloma (LCMM), the free light chains are filtered immediately through the glomeruli and do not form an M-spike on serum electrophoresis.
• In non-secretory myeloma, no paraprotein is exported.
• Golden Diagnostic Rule: Screening for plasma cell disorders MUST ALWAYS combine SPEP + Serum Immunofixation (IFE) + Serum Free Light Chain (sFLC) assay.
• Negative Urine Dipstick in Myeloma Nephropathy:
• Standard urine test strips utilize colorimetric dye binding that is specific for albumin.
• Nephrotoxic Bence Jones proteins (free kappa/lambda light chains) are completely missed by dipstick testing! A patient dying of light-chain cast nephropathy can have a "trace" or "negative" dipstick. Always order a spot urine protein-to-creatinine ratio (PCR) or 24-hour urine protein electrophoresis (UPEP).

> [!CAUTION] > Immediate Hematology Consultation Triggers: > 1. M-Protein Spike $\ge 30\text{ g/L}$ ($\ge 3.0\text{ g/dL}$): High tumor burden; warrants urgent bone marrow biopsy and skeletal staging. > 2. Paraprotein with Acute Oliguric Renal Failure: Strongly suggests light chain cast nephropathy; requires urgent hydration, dexamethasone, and bortezomib induction to rescue nephrons. > 3. Serum Viscosity $> 4.0\text{ cP}$ with Neurological Signs: Hyperviscosity crisis (stupor, retinal hemorrhages, mucosal hemorrhage; commonest in IgM Waldenström); warrants emergency therapeutic plasma exchange (plasmapheresis).

• Immunoglobulin Distribution in Multiple Myeloma:
• IgG: sim 50–55% of cases.
• IgA: sim 20–25% of cases (frequently migrates in the β-zone rather than gamma!).
• Light Chain Only: sim 15–20% of cases (missed on SPEP).
• IgD: sim 1–2% (frequently lambda light chain, aggressive, young patients).
• IgM: < 0.5% (monoclonal IgM with lymphoplasmacytic marrow infiltration defines Waldenström macroglobulinemia, NOT multiple myeloma).
• CRAB Criteria Mnemonic:
• C: Calcium elevated (> 11 mg/dL or > 1 mg/dL above normal).
• R: Renal insufficiency (Creatinine > 2.0 mg/dL or eGFR < 40 mL/min).
• A: Anemia (Hemoglobin < 10 g/dL or > 2 g/dL below normal).
• B: Bone lesions (≥ 1 osteolytic lesions on skeletal CT or MRI).
• Rouleaux Formation: High serum concentrations of paraprotein neutralize the negative zeta potential of red blood cells, causing them to stack like coins on the peripheral blood film.

• Complete Blood Count & Peripheral Blood Film: Identifies normocytic anemia, thrombocytopenia, and striking red cell rouleaux formation.
• Renal Function Tests & eGFR: Identifies light chain cast nephropathy, amyloid deposition, or hypercalcemic tubulopathy.
• Serum Free Light Chain Assay (sFLC): Quantifies free kappa and lambda light chains, calculating the diagnostic kappa/lambda ratio.
• Serum Electrolytes & Calcium: Critical detection of hypercalcemia (> 11 mg/dL) and low anion gap (cationic IgG paraprotein artifactually reduces calculated serum anion gap!).